✦ LIBER ✦

Non-transferrin bound labile plasma iron and iron overload in Sickle Cell Disease: a comparative study between Sickle Cell Disease and β thalassemic patients

✍ Scribed by Ariel Koren; Daniel Fink; Osnat Admoni; Yardena Tennenbaum-Rakover; Carina Levin

Book ID: 114794667
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 100 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01342.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nontransferrin-bound iron in transfused

Nontransferrin-bound iron in transfused patients with sickle cell disease

✍ A. INATI; K. M. MUSALLAM; M. D. CAPPELLINI; L. DUCA; A. T. TAHER 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Oxidative stress and inflammation in iro

Oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease

✍ Patrick B. Walter; Ellen B. Fung; David W. Killilea; Qing Jiang; Mark Hudes; Jac 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Increased prevalence of iron-overload as

Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease

✍ Ellen B. Fung; Paul R. Harmatz; Phillip D.K. Lee; Meredith Milet; Rita Bellevue; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Disparity in the management of iron over

Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions

✍ Ellen B. Fung; Paul R. Harmatz; Meredith Milet; Vinod Balasa; Samir K. Ballas; J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Morbidity and mortality in chronically t

Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload

✍ Ellen B. Fung; Paul Harmatz; Meredith Milet; Samir K. Ballas; Laura De Castro; W 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (Tx‐SCD, __n__ = 199), and 64 non‐Tx‐SCD subjects to describe the frequency of iron‐related morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si